// App-Quantinova.ai

OP0177 : RANDOMIZED COMPARISON OF TRIPLE DMARD THERAPY WITH METHOTREXATE MONO-THERAPY

Researchers

Presenter

  • P. H. P. De Jong

Principal Investigators

  • J. M. Hazes

  • J. J. Luime

  • A. E. Weel

Medical Centers

  • Immunology, Erasmus MC, Rotterdam, Netherlands

Locations

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory Arthritis

Biomarkers

  • Albumin/creatinine

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • sulphasalazine

  • Methotrexate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved